Leukemia single-chain antibody library, as well as construction method and application thereof
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- ZHEJIANG UNIV
- Publication Date
- 2015-02-25
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The invention belongs to genetic engineering, and relates to a fully human leukemia single-chain antibody library and its construction method, and its application in the preparation of leukemia antibody medicine. Background technique
[0002] since Since he and Milstein founded lymphocyte hybridoma technology, monoclonal antibodies have been widely used in the field of tumor diagnosis and treatment. The first generation of mouse monoclonal antibody used in the treatment of human diseases is mainly mouse-derived monoclonal antibody, but the main disadvantage of mouse monoclonal antibody is that it causes the human immune response, and the human anti-mouse antibody produced by the human body makes it clear quickly and cannot play its biological role well Therefore, the clinical application is limited; the second-generation antibody is based on the mouse monoclonal antibody and forms a chimeric antibody and a humanized antibody through gene recombinatio...